German Medical Device Manufacturers: Exports 2026

German medical device and precision instrument makers sold EUR 28.2 billion abroad in 2024, or 68.1% of the industry’s EUR 41.4 billion revenue, according to SPECTARIS industry figures. Exporting is not the problem. The problem in 2026 is that the destinations carrying the growth are the ones German manufacturers cover most thinly, while the channels built to cover them keep getting more expensive.

Where German medical device exports actually go

The destination list is short at the top and heavily weighted toward mature markets. Germany shipped USD 17.26 billion of instruments and apparatus for medical, surgical and dental use in 2024, which makes it the third largest supplier worldwide after the United States and China, per the federal trade agency Germany Trade and Invest and its UN Comtrade breakdown.

Destination	2024 exports, USD m	Share
United States	2,932.5	17%
Netherlands	1,273.1	7%
France	1,180.2	7%
China	977.5	6%
Switzerland	809.8	5%
Saudi Arabia	237.6	1%
India	235.6	1%

The Dutch figure is partly other people’s demand. GTAI notes that a substantial share of German exports moves through the Netherlands and Belgium as European logistics hubs before onward shipment to third countries. Across all medtech, SPECTARIS puts the EU at 39.6% of German exports, North America at 19.6%, Asia at 15.6%, the Middle East at 2.0% and Africa at 1.4%.

So the export book is concentrated in the two regions where hospital capex grows slowly and procurement is already consolidated. The regions adding hospital beds fastest account for a rounding error of German shipments.

How many German medtech firms have no export sales organisation

Most of them. SPECTARIS counts 1,508 manufacturing sites with 20 or more employees, of which 967 employ between 20 and 49 people. BVMed puts the share of German medtech companies with fewer than 250 employees at 93%, and the share of industry turnover earned abroad at roughly 68%. The sector is small-company heavy and export-exposed at the same time.

Below the 20-employee reporting threshold sits a second industry the statistics barely see: another 9,500 micro-enterprises employing about 96,000 people. The City of Tuttlingen’s own cluster description counts over 400 companies in the district and states that the vast majority have fewer than 20 employees.

Picture the typical exporter accurately. Thirty-five people, two thirds of revenue from abroad, one technical sales lead, a distributor list assembled over twenty years, and a booth budget. There is no regional sales organisation to redirect when a market cools. Our Tuttlingen surgical instrument guide covers that cluster in detail.

What changed for German medtech exporters in 2026

The two largest single destinations both became harder inside eighteen months. Under the EU and US trade framework, in force since 1 July 2026, a 15% tariff ceiling applies to most EU exports. The named zero-tariff categories cover aircraft parts, certain natural resources and generic pharmaceuticals. Medical devices are not among them, so they sit under the general ceiling.

China moved the other way on its own. SPECTARIS reported German medtech exports to China down 14% in 2024, and still declining through the first half of 2025 while total exports rose 7.5%, with growth coming particularly from Europe and the Middle East.

The home market is not compensating. In the BVMed autumn 2025 survey of 116 companies, members expected 3.1% domestic revenue growth against 5.5% worldwide. Just over half reported a worsening profit outlook, 40% named tariffs and trade barriers as an obstacle, and 31% said they were shifting investment abroad.

Certification timing adds a second constraint that sales planning tends to ignore. The Team-NB survey of European notified bodies recorded 13,953 cumulative MDR certificates against 25,978 applications at the end of 2025, and found that 70% of new MDR certificates took more than twelve months to issue, with 48% landing in the 13 to 18 month band.

Those dates are fixed by regulation, not by the commercial calendar. Regulation (EU) 2023/607 runs the transition to 31 December 2027 for class III and implantable class IIb devices, and to 31 December 2028 for most other class IIa and IIb devices. The Commission’s December 2025 simplification proposal is now working through Parliament and Council.

A product reaches the market when its certificate arrives, not when the sales plan says so. If nobody warmed the buyers during the wait, the launch window opens onto an empty list.

What a trade fair costs a German medtech exporter now

More than most SMEs model, and the fair calendar points at the wrong regions. MEDICA and COMPAMED remain the strongest medtech meeting in the world: more than 5,300 exhibitors from 70 nations and 78,000 trade visitors from 160 countries in November 2025, three quarters of them in top management.

The entry price is public. Messe Düsseldorf’s own MEDICA stand cost calculator prices a 2026 row stand at EUR 304 per square metre, with a 12 square metre minimum and a EUR 995 media charge. That is roughly EUR 4,700 net before a single panel is built. AUMA and Prognos put average spend per exhibitor at a capital-goods trade fair at EUR 66,800, with stand rental and construction taking 64% of that budget.

German exhibitors are already rationing. In the AUMA exhibitor outlook for 2026 and 2027, based on 404 interviews conducted in late 2025, 64.1% named rising costs as their leading challenge and 83.4% said the cost-benefit ratio decides which region they exhibit in.

Average participations slip from 5.4 to a forecast 5.1, and the study records that reductions are most pronounced at capital-goods fairs. Those same exhibitors still rate fairs important, at 85.4%. They are prioritising fewer events, not walking away from the format.

Then there is the geography problem. analytica 2026 in Munich, the anchor event for German laboratory instrument makers, drew 35,033 visitors from 115 countries, and 83% of them came from the EU. The affordable, well-run fairs sell you deeper into the region you already serve.

Reaching the growth regions is exactly where the subsidised route thinned out. For 2026 the federal foreign trade fair programme funds 236 joint participations in more than 50 countries on a EUR 44 million budget. But AUMA reports the number of German Pavilions fell 10% year on year while the cost of exhibiting abroad has risen by up to 40%.

The country allocation runs 32 stands in the USA, 27 in China, 23 in the UAE, 20 in India and 10 each in Saudi Arabia and Singapore. That is ten subsidised stands in Saudi Arabia for the whole of German industry, in a market that took USD 237.6 million of German instruments in 2024.

What field reps and distributors actually cover

One or two markets each, at a cost floor set by German labour economics. Destatis put labour costs in manufacturing at EUR 49.50 per hour in 2025, and median full-time gross annual pay at EUR 54,066, with non-wage costs adding EUR 29 for every EUR 100 of gross earnings.

Combine those official components and a fully loaded technical sales hire starts near EUR 76,000 to EUR 82,000 a year before a company car. A specialist device rep with clinical vocabulary and a second working language sits above that median.

Distributors carry a second cost beyond margin. Margin itself is negotiated market by market and rarely published. The less visible cost is the information the manufacturer never receives. Under an exclusive agreement in the Gulf or Southeast Asia, the manufacturer does not learn which hospital reordered, which competitor was benchmarked against it, or when the next tender was published. Those are the inputs a targeting system runs on.

Cold calling is the usual fallback and it does not close the gap. Calling procurement leads across fifteen countries in their working language, with the local registration rules in your head, is a job for a sales floor, not for a 35-person manufacturer with one export lead.

What a systematic outbound engine changes for a German exporter

It puts continuous coverage exactly where the fair calendar and the rep map do not reach. Saudi Arabia bought USD 237.6 million of German medical, surgical and dental instruments in 2024 and India USD 235.6 million. Both are growing, both are about 1% of the export book, and both are served by a handful of subsidised stands a year and no resident salesperson.

An outbound engine researches each account before it writes: the hospital group’s expansion announcements, the tender platform it publishes on, its existing supplier mix, the registration standard it requires. Then it writes in the buyer’s language and follows up on a schedule nobody has to remember. Your regulatory and clinical people only join once a reply comes back qualified.

Channel	What it commits you to	How it scales	Markets covered
Outbound engine	Monthly, no headcount	Add markets without adding people	6 or more at once
Capital-goods trade fair	EUR 66,800 average per fair	Each new region is another full participation	Whoever walks the hall
Field sales representative	EUR 76,000 to 82,000 and up	Each new region is another salary	1 to 2
Exclusive distributor	Margin plus lost buyer data	Their appetite, not your plan	Their territory only

The direction of travel matters more than the entry price. A fair costs the same EUR 66,800 in year five as in year one, and a second territory means a second rep on the payroll. An outbound engine gets cheaper per qualified conversation as it runs, because each cycle sharpens which buyer profiles reply, which regions convert and which signals precede a purchase. Our own published rate is $150 to $300 per qualified lead, and it moves down the longer the engine runs on your category.

The certification queue makes the timing argument for you. If a new MDR certificate typically takes 13 to 18 months, that window is available for pipeline work at almost no incremental cost. The alternative is to start selling on the day the certificate lands, from zero.

The bottom line

German medtech earns roughly 68% of its revenue abroad and is built almost entirely of small companies. That combination worked while the United States, France and China absorbed the volume and the fair calendar covered the rest.

In 2026 the tariff ceiling, softer Chinese demand and a shrinking pavilion programme all point the same way. The growth sits in markets the current channels were never built to reach.

If you manufacture medical devices or precision instruments in Germany and want systematic coverage of the markets your fair calendar misses, see how the engine works or start a conversation with us. We will map your current destination mix against where your category is actually growing.

Sourcing from these manufacturers? Send us your RFQ and we will map and shortlist qualified German suppliers.

Frequently asked questions

Which export markets should a German medtech SME open next?

Look at where your category is growing rather than where the fair calendar goes. SPECTARIS reports German medtech export growth of 7.5% in the first half of 2025, led by Europe and the Middle East, while China declined. Saudi Arabia, India, Türkiye and South Korea each took between USD 200 and 240 million of German instruments in 2024 on small bases.

Is MEDICA still worth the money for a 40-person manufacturer?

Usually yes, as one channel rather than the channel. A 12 square metre row stand starts near EUR 4,700 in fees alone, and AUMA puts real average exhibitor spend at a capital-goods fair at EUR 66,800. That is defensible for demonstrations and existing customers. It is expensive as your only route to buyers in fifteen countries.

Our MDR certificate is still in the queue. Is it too early to build a pipeline?

It is the right time. Team-NB data shows 70% of new MDR certificates take over twelve months, with most landing between 13 and 18 months. That window is free pipeline time. Buyers can be identified, qualified and educated while certification runs, so the launch meets a warm list instead of a cold market.

How do we sell direct without damaging our distributor relationships?

Start where you have no distributor. Most German medtech SMEs have coverage in five to eight countries and none in another thirty. Direct outreach into unassigned territory creates no conflict, and it generates the buyer data you currently never see. Many manufacturers then use that evidence to renegotiate or to appoint better partners.

Do we need native speakers in each target market?

Not on payroll. Outreach can be written in the buyer’s working language from the start, which is what gets a reply from a procurement lead in Riyadh or São Paulo. Your own team enters the conversation only after a qualified response, and by then English or a call with the local partner usually suffices.